DEF 14A

Company

NEKTAR THERAPEUTICS

Filed

May 1, 2001

Period of Report

June 1, 2001

Accession Number

0000912057-01-511769

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →